HbA1c Control Set 502-156

GUDID 00812137012166

This product is for the purpose of monitoring accuracy and precision in the quantitative determination of human hemoglobin A1c (HbA1c) in blood by automated immunoassay. For in vitro diagnostic use only. Throughout the circulatory life of the red cell, Hemoglobin A1c is formed continuously by the adduction of glucose to the N-terminal of the hemoglobin beta chain. This process, which is non-enzymatic, reflects the average exposure of hemoglobin to glucose over an extended period.

CLINICAL DIAGNOSTIC SOLUTIONS, INC.

Glycated haemoglobin (HbA1c) IVD, control Glycated haemoglobin (HbA1c) IVD, control
Primary Device ID00812137012166
NIH Device Record Key9c9f522e-5a16-4b3f-8b08-0363b6c8b44f
Commercial Distribution StatusIn Commercial Distribution
Brand NameHbA1c Control Set
Version Model NumberL1 x 2 x 0.5mL, L2 x 2 x 0.5mL
Catalog Number502-156
Company DUNS048144997
Company NameCLINICAL DIAGNOSTIC SOLUTIONS, INC.
Device Count4
DM Exempttrue
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Producttrue
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Customer Support Contacts

Phone8004533328
Emailquality@cdsolinc.com
Phone8004533328
Emailquality@cdsolinc.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS100812137012166 [Primary]
GS100812137012449 [Unit of Use]

FDA Product Code

LCPAssay, Glycosylated Hemoglobin

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number2
Public Version Date2018-03-29
Device Publish Date2016-10-13

Devices Manufactured by CLINICAL DIAGNOSTIC SOLUTIONS, INC.

00001812701208 - Triglycerides Reagent2020-03-31 For the in vitro quantitative determination of Triglycerides in serum or plasma. Triglycerides determinations are of interest in
00812137011848 - Albumin Reagent2020-03-31 For the quantitative determination of Albumin in serum.
00812137010254 - CDS-LTX CONTROL2018-07-06 CDS-LTX Control is used to validate volume, conductivity and light scatter parameters on COULTER HmX/ MAXM, STKS and GEN-S in
00812137010261 - CDS-LTX PRIMER2018-07-06 CDS-LTX Primer is used to prepare the tubing and instrument components on the COULTER HmX/MAXM, STKS and GEN-S instruments pr
00812137011947 - Carbon Dioxide Reagent2018-06-11 For the quantitative determination of Carbon Dioxide in serum. For in vitro diagnostic use only.
00812137011916 - Urea Nitrogen Reagent Set2018-04-17 For the quantitative determination of urea nitrogen in serum. For in vitro diagnostic use only. Determination of urea nitrogen
00081213701184 - Albumin Reagent2018-03-29 For the quantitative determination of Albumin in serum.
00812137010216 - Boule Con-Diff Tri-Level2018-03-29 For in vitro diagnostic use as a control to monitor the performance of multi- parameter hematology instruments. Boule Con-Diff T

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.